Profil
Timothy J.
Whitaker is currently Director at Southern New Hampshire Medical Center.
Formerly, Dr. Whitaker was Chief Medical Officer at Seelos Therapeutics, Inc. from 2021 to 2024, Chief Medical Officer at Vallon Pharmaceuticals, Inc. from 2018 to 2023, Chief Medical Officer at Lundbeck Seattle BioPharmaceuticals, Inc. from 2016 to 2017, VP & Head-Neuroscience Therapeutic Area at Shire Plc from 2004 to 2016, Senior Director-Neuroscience at Wyeth Pharmaceuticals LLC from 1996 to 2004, and Associate Professor at the University of Vermont College of Medicine from 1988 to 1996.
Education includes undergraduate studies at Duke University and a doctorate from Wake Forest University.
Postes actifs de Timothy J Whitaker
| Sociétés | Poste | Début |
|---|---|---|
Southern New Hampshire Medical Center
Southern New Hampshire Medical Center Hospital/Nursing ManagementHealth Services Provides health care services | Directeur/Membre du Conseil | - |
Anciens postes connus de Timothy J Whitaker
| Sociétés | Poste | Fin |
|---|---|---|
| SEELOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
| GRI BIOPAR | Directeur Technique/Scientifique/R&D | 21/04/2023 |
| ALDER BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2017 |
| SHIRE | Corporate Officer/Principal | 01/01/2016 |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | 01/01/2004 |
Formation de Timothy J Whitaker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern New Hampshire Medical Center
Southern New Hampshire Medical Center Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
University of Vermont College of Medicine
University of Vermont College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neurological disorders and rare diseases using pipeline targeting CNS conditions | Health Technology |
Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
















